Intrinsic Value of S&P & Nasdaq Contact Us

Erasca, Inc. ERAS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.60
-35%

Stock Statistics — ERAS

Erasca, Inc. (ERAS) has a market capitalization of $5.55B and trades at $17.85. The 52-week range is 1.01-18.18.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -40.6, Earnings Per Share (EPS) of $-0.44.

The stock has a beta of 1.05, operates in the Healthcare sector.

Trading Data
Current Price$17.85
52-Week Range1.01-18.18
Volume5.27M
Avg Volume (30D)5.68M
Market Cap$5.55B
Beta (1Y)1.05
Company
IPO Date2021-07-16
Employees103
CEOJonathan E. Lim
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS29479A1088
CUSIP29479A108
Income (Latest Year)
Gross Profit$-3.11M
EBITDA$-128.3M
Operating Income$-131.41M
Net Income$-124.55M
EPS$-0.44
EPS Diluted$-0.44
Shares Outstanding$283.53M
Balance Sheet (Latest Year)
Total Assets$396.15M
Current Assets$286.24M
Cash & ST Investments$276.08M
Total Liabilities$70.98M
Total Debt$47.14M
Net Debt$-26.67M
Total Equity$325.17M
Debt / Equity0.14
Valuation Ratios
P/E Ratio-40.6
P/B Ratio17.06
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message